Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(10 sites)
Democratic Republic of the Congo
Catholic University of Bukavu, Kinshasa, Bukavu Nigeria
Federal Medical Center, Abuja University of Abuja Teaching Hospital, Abuja University of Ibadan, Ibadan Irrua Specialist Teaching Hospital, Irrua Aminu Kano Teaching Hospital, Kano Lagos University Teaching Hospital, Lagos Niger Delta Teaching Hospital, Okolobiri University of Port Harcourt Teaching Hospital, Port Harcourt Uganda
Makerere University Lung Institute, Kampala